Search

Objective. To study the effectiveness and safety of simethicone and phytocomponents («Espicol Baby») for the treatment of intestinal colic in infants with food intolerance. Patients and methods. A total of 70 children of the first year of life were under observation. Inclusion criteria for the examination were established diagnosis of food intolerances and the presence of abdominal pain syndrome (intestinal colic). The main group consisted of 45 children who had received in addition to the complex treatment Espicol Baby and the control group — 25 children who had received only non-pharmacological treatment. Results. The high efficiency of «Espicol Baby» preparation (over 90%) in the treatment of intestinal colic is found. Most children had pronounced clinical effect during the application of a preparation in a dose of 1.0 ml of the suspension (40 mg simethicone) at each baby feeding. The absence of side effects or allergic reactions during the use of preparation certify about its good tolerability and high safety profile. Conclusions. In the pathogenesis of intestinal colic in infants with food intolerances the important role plays flatulence and motility disorders of the digestive tract that is pathogenetically justified the inclusion of preparations with in carminative action (simethicone) to the therapeutic complex.